DeepUll is a Spanish medical diagnostics company focused on developing rapid, culture-free diagnostic solutions for sepsis and other acute infections. Their technology aims to identify pathogens and antibiotic resistance markers directly from blood samples within approximately one hour, providing up to 50 reportable results. This approach addresses the critical need for early detection in sepsis management, potentially reducing the significant morbidity and mortality associated with delayed diagnosis. Founded in 2019, DeepUll is headquartered at the Barcelona Science Park.?

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jordi Carrera

Browse more venture capital transactions:

Prev: 4/30/2025: Terminal 3 venture capital transaction
Next: 4/30/2025: Faye venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary